CN104522493A - 治疗冠状动脉粥样硬化的养生粥及制备方法 - Google Patents
治疗冠状动脉粥样硬化的养生粥及制备方法 Download PDFInfo
- Publication number
- CN104522493A CN104522493A CN201410762969.2A CN201410762969A CN104522493A CN 104522493 A CN104522493 A CN 104522493A CN 201410762969 A CN201410762969 A CN 201410762969A CN 104522493 A CN104522493 A CN 104522493A
- Authority
- CN
- China
- Prior art keywords
- health
- parts
- seed
- job
- tears
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000021395 porridge Nutrition 0.000 title claims abstract description 50
- 208000029078 coronary artery disease Diseases 0.000 title claims abstract description 43
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 title claims abstract description 37
- 208000026758 coronary atherosclerosis Diseases 0.000 title claims abstract description 37
- 238000002360 preparation method Methods 0.000 title claims description 22
- 230000036541 health Effects 0.000 title abstract description 8
- 239000003814 drug Substances 0.000 claims abstract description 40
- 239000004575 stone Substances 0.000 claims abstract description 28
- 241000218176 Corydalis Species 0.000 claims abstract description 26
- 235000003373 curcuma longa Nutrition 0.000 claims abstract description 24
- 241000801118 Lepidium Species 0.000 claims abstract description 23
- 244000197580 Poria cocos Species 0.000 claims abstract description 23
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 23
- 235000008100 Ginkgo biloba Nutrition 0.000 claims abstract description 22
- 241000237536 Mytilus edulis Species 0.000 claims abstract description 20
- 235000020638 mussel Nutrition 0.000 claims abstract description 20
- 244000163122 Curcuma domestica Species 0.000 claims abstract description 6
- 241000209205 Coix Species 0.000 claims description 36
- 235000007354 Coix lacryma jobi Nutrition 0.000 claims description 36
- 241001251949 Xanthium sibiricum Species 0.000 claims description 25
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 24
- 241000018646 Pinus brutia Species 0.000 claims description 24
- 235000011613 Pinus brutia Nutrition 0.000 claims description 24
- 235000003392 Curcuma domestica Nutrition 0.000 claims description 23
- 235000013976 turmeric Nutrition 0.000 claims description 23
- 241000218628 Ginkgo Species 0.000 claims description 21
- 235000011201 Ginkgo Nutrition 0.000 claims description 21
- 239000009636 Huang Qi Substances 0.000 claims description 20
- 235000018905 epimedium Nutrition 0.000 claims description 19
- 241001016310 Epimedium grandiflorum Species 0.000 claims description 18
- 239000006228 supernatant Substances 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 235000012907 honey Nutrition 0.000 claims description 14
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000009835 boiling Methods 0.000 claims description 7
- 239000012467 final product Substances 0.000 claims description 7
- 238000005242 forging Methods 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 7
- 238000002386 leaching Methods 0.000 claims description 7
- 239000000155 melt Substances 0.000 claims description 7
- 238000002791 soaking Methods 0.000 claims description 7
- 238000003756 stirring Methods 0.000 claims description 7
- 206010061216 Infarction Diseases 0.000 claims description 3
- 230000007574 infarction Effects 0.000 claims description 3
- 208000010125 myocardial infarction Diseases 0.000 claims description 3
- IZEKFCXSFNUWAM-UHFFFAOYSA-N dipyridamole Chemical compound C=12N=C(N(CCO)CCO)N=C(N3CCCCC3)C2=NC(N(CCO)CCO)=NC=1N1CCCCC1 IZEKFCXSFNUWAM-UHFFFAOYSA-N 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 16
- 210000004369 blood Anatomy 0.000 abstract description 15
- 230000000694 effects Effects 0.000 abstract description 14
- 208000002193 Pain Diseases 0.000 abstract description 13
- 230000036407 pain Effects 0.000 abstract description 12
- 239000000463 material Substances 0.000 abstract description 6
- 239000000203 mixture Substances 0.000 abstract description 6
- 241000382455 Angelica sinensis Species 0.000 abstract description 2
- 244000183685 Citrus aurantium Species 0.000 abstract description 2
- 230000003213 activating effect Effects 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- SMDOOINVMJSDPS-UHFFFAOYSA-N Astragaloside Natural products C1=C(O)C(OC)=CC(C2=C(C(=O)C3=C(O)C=C(O)C=C3O2)OC2C(C(OC3C(C(O)C(O)C(CO)O3)O)C(O)C(CO)O2)O)=C1 SMDOOINVMJSDPS-UHFFFAOYSA-N 0.000 abstract 1
- 235000007716 Citrus aurantium Nutrition 0.000 abstract 1
- 244000077995 Coix lacryma jobi Species 0.000 abstract 1
- 241000601090 Equisetum pratense Species 0.000 abstract 1
- 244000194101 Ginkgo biloba Species 0.000 abstract 1
- QMNWISYXSJWHRY-XWJCTJPOSA-N astragaloside Chemical compound O1[C@H](C(C)(O)C)CC[C@]1(C)[C@@H]1[C@@]2(C)CC[C@]34C[C@]4(CC[C@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)CO4)O)C4(C)C)C4[C@@H](O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)CC3[C@]2(C)C[C@@H]1O QMNWISYXSJWHRY-XWJCTJPOSA-N 0.000 abstract 1
- 239000008187 granular material Substances 0.000 abstract 1
- 230000003340 mental effect Effects 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
- 244000008991 Curcuma longa Species 0.000 description 18
- 102000007330 LDL Lipoproteins Human genes 0.000 description 13
- 108010007622 LDL Lipoproteins Proteins 0.000 description 13
- 208000024891 symptom Diseases 0.000 description 13
- 230000003143 atherosclerotic effect Effects 0.000 description 11
- 210000000038 chest Anatomy 0.000 description 11
- 210000001367 artery Anatomy 0.000 description 10
- 210000004351 coronary vessel Anatomy 0.000 description 7
- 210000004072 lung Anatomy 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 208000007536 Thrombosis Diseases 0.000 description 6
- 206010025482 malaise Diseases 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 210000004204 blood vessel Anatomy 0.000 description 5
- 210000000497 foam cell Anatomy 0.000 description 5
- 201000001320 Atherosclerosis Diseases 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 4
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- -1 compound carbohydrate Chemical class 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000035619 diuresis Effects 0.000 description 4
- 210000003128 head Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 208000037093 Menstruation Disturbances Diseases 0.000 description 3
- 206010027339 Menstruation irregular Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010036790 Productive cough Diseases 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- 238000002583 angiography Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 230000036770 blood supply Effects 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000001616 monocyte Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 231100000614 poison Toxicity 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 210000000952 spleen Anatomy 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- CPLXHLVBOLITMK-UHFFFAOYSA-N Magnesium oxide Chemical compound [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 208000012287 Prolapse Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 244000061458 Solanum melongena Species 0.000 description 2
- 235000002597 Solanum melongena Nutrition 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000036523 atherogenesis Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 206010008118 cerebral infarction Diseases 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 201000006549 dyspepsia Diseases 0.000 description 2
- 210000002889 endothelial cell Anatomy 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 208000004371 toothache Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 description 1
- MCSXGCZMEPXKIW-UHFFFAOYSA-N 3-hydroxy-4-[(4-methyl-2-nitrophenyl)diazenyl]-N-(3-nitrophenyl)naphthalene-2-carboxamide Chemical compound Cc1ccc(N=Nc2c(O)c(cc3ccccc23)C(=O)Nc2cccc(c2)[N+]([O-])=O)c(c1)[N+]([O-])=O MCSXGCZMEPXKIW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000242323 Anchusa officinalis Species 0.000 description 1
- 235000017847 Anchusa officinalis Nutrition 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 241000512259 Ascophyllum nodosum Species 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 241000282461 Canis lupus Species 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010008479 Chest Pain Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001391944 Commicarpus scandens Species 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010010970 Cor pulmonale chronic Diseases 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000424773 Epimedium alpinum Species 0.000 description 1
- 241000195952 Equisetaceae Species 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000014770 Foot disease Diseases 0.000 description 1
- 241000222336 Ganoderma Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 244000062245 Hedychium flavescens Species 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 206010027627 Miliaria Diseases 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 240000002948 Ophiopogon intermedius Species 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000131316 Panax pseudoginseng Species 0.000 description 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 240000007711 Peperomia pellucida Species 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 241001674048 Phthiraptera Species 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 241001558929 Sclerotium <basidiomycota> Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- HATRDXDCPOXQJX-UHFFFAOYSA-N Thapsigargin Natural products CCCCCCCC(=O)OC1C(OC(O)C(=C/C)C)C(=C2C3OC(=O)C(C)(O)C3(O)C(CC(C)(OC(=O)C)C12)OC(=O)CCC)C HATRDXDCPOXQJX-UHFFFAOYSA-N 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 240000008866 Ziziphus nummularia Species 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000001466 anti-adreneric effect Effects 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 230000000916 dilatatory effect Effects 0.000 description 1
- YWEUIGNSBFLMFL-UHFFFAOYSA-N diphosphonate Chemical compound O=P(=O)OP(=O)=O YWEUIGNSBFLMFL-UHFFFAOYSA-N 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001856 erectile effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 235000002864 food coloring agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 210000004220 fundus oculi Anatomy 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 208000027906 leg weakness Diseases 0.000 description 1
- 229960004194 lidocaine Drugs 0.000 description 1
- 150000004668 long chain fatty acids Chemical class 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 208000002780 macular degeneration Diseases 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- IUBSYMUCCVWXPE-UHFFFAOYSA-N metoprolol Chemical compound COCCC1=CC=C(OCC(O)CNC(C)C)C=C1 IUBSYMUCCVWXPE-UHFFFAOYSA-N 0.000 description 1
- 229960002237 metoprolol Drugs 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 201000004169 miliaria rubra Diseases 0.000 description 1
- JKQOBWVOAYFWKG-UHFFFAOYSA-N molybdenum trioxide Chemical compound O=[Mo](=O)=O JKQOBWVOAYFWKG-UHFFFAOYSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 description 1
- 229960002748 norepinephrine Drugs 0.000 description 1
- VIKNJXKGJWUCNN-XGXHKTLJSA-N norethisterone Chemical compound O=C1CC[C@@H]2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 VIKNJXKGJWUCNN-XGXHKTLJSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 208000021090 palsy Diseases 0.000 description 1
- 244000138993 panchioli Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000010412 perfusion Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- DLYUQMMRRRQYAE-UHFFFAOYSA-N phosphorus pentoxide Inorganic materials O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 239000005871 repellent Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229930009674 sesquiterpene lactone Natural products 0.000 description 1
- 150000002107 sesquiterpene lactone derivatives Chemical class 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 210000001562 sternum Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000003932 urinary bladder Anatomy 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 239000005526 vasoconstrictor agent Substances 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗冠状动脉粥样硬化的养生粥,主要由下列原料药制备而成,均为重量份:葶苈子2-6,苍耳子1-5,草问荆2-3,麦饭石2-6,延胡索3-8,姜黄3-6,枳壳1-5,淡菜1-5,淫羊藿2-5,银杏叶4-7,茯苓3-7,当归4-10,黄芪3-9,薏米20-40。本发明的优良效果还表现在:所选材料皆为传统中药材料,无任何毒副作用;本组方完全符合中医药原则和冠心病患者身心特点,在总原则的前提下,可根据不同人群有不同组方,功能不同,本发明冲剂具有活血通经,散淤止痛功效,对治疗动脉粥样硬化与冠心病有特殊的疗效。
Description
技术领域
本发明涉及中医中药领域,特别是涉及一种治疗冠状动脉粥样硬化的养生粥及其制备方法。
背景技术
动脉粥样硬化(Atherosclerosis)是动脉硬化中最常见而重要的类型,其特点是受累动脉的内膜有类脂质的沉着,复合糖类的积聚,继而纤维组织增生和钙沉着,并有动脉中层的病变。本病主要累及大型及中型的肌弹力型动脉,以主动脉、冠状动脉及脑动脉为多见,常导致管腔闭塞或管壁破裂出血等严重后果。发生在冠状动脉上的动脉粥样硬化称为冠状动脉粥样硬化(Coronary Atherosclerotic )。它是最常见的狭窄性冠状动脉疾病,特别是肌壁外冠状动脉支的动脉粥样硬化。冠状动脉近侧段之所以好发动脉粥样硬化是由于它比所有器官动脉都靠近心室,因而承受最大的收缩压撞击。再者,冠状动脉血管树由于心脏的形状而有多数方向改变,因此亦承受较大的血流剪应力。
好发部位:据我国的尸检统计资料,病变的总检出率、狭窄检出率和平均级别均以前降支最高,其余依次为右主干、左主干或左旋支、后降支。性别差异:20~50岁病变检出率,男性显著高于女性;60岁以后男女无明显差异。动脉粥样硬化是导致一系列心、脑血管病的基础,以下我们就来简单的讲述一下动脉粥样硬化形成的机理。氧化的低密度脂蛋白(Ox-LDL)是动脉粥样硬化的核心,当血液中的低密度脂蛋白(LDL)被活性氧(ROS)等自由基氧化后叫着“氧化的低密度脂蛋白”简称“Ox-LDL”,他就会进入血管壁,1.Ox-LDL损坏血管壁的内皮细胞,并且让内皮细胞间隙变大;2.Ox-LDL刺激单核细胞游走进入血管壁;3.OX-LDL被巨噬细胞以及血管的平滑肌细胞的受体所吞噬,----形成泡沫细胞,4.Ox-LDL使上述两种泡沫细胞坏死崩解,形成糜粥样坏死物,粥样硬化斑块形成。
这里要特别强调的是氧化的低密度脂蛋白(Ox-LDL)在整个动脉粥样硬化形成过程中起了核心作用,而不是我们老百姓一般认为的“低密度脂蛋白”或者“血脂”或者“胆固醇”概念,如果LDL不被氧化为Ox-LDL,机体的单核细胞认为LDL是“自己人”,不会对他(LDL)进行吞噬并形成泡沫细胞,只有当他(LDL)被氧化成Ox-LDL后,才被机体的单核细胞等炎症介质认为是【异己】成分,并对之进行吞噬,消灭,最终形成泡沫细胞。因此防止LDL氧化为Ox-LDL是遏制动脉粥样硬化的关键所在,而不是我们常规理解的降低胆固醇、降低血脂、降低低密度脂蛋白(LDL)等。动脉粥样硬化后的血管,血栓的形成是一个比较复杂的炎症过程。随着上述动脉粥样硬化斑块的生长,常常是导致上述泡沫细胞死亡,形成坏死性核心,他能与持续存在的炎症反应,使上述粥样硬化斑块变得很不稳定,活化的巨噬细胞分泌一种酶降解胶原纤维帽,不稳定斑块形成,这样就很容易破裂。破裂后的斑块大量高度致凝血的物质释放入血管腔,导致局部血栓形成。当这种血栓形成在脑部的血管,则叫脑血栓(脑梗塞、脑梗死),当脑血管处在一个薄弱的部位而且伴有高血压之类,或者斑块向血管外破裂就形成了脑出血,这两类情况中医叫中风、西医叫卒中;当这种血栓形成在心脏的冠状动脉,就叫心肌梗死(心肌梗塞);当这种血栓形成发生在眼底动脉,则就是黄斑变性。当这种血栓的形成出现在下肢动脉的时候,就导致像糖尿病的病足之类的改变。
申请公布号 CN 102973786 A(申请号 201210441546.1)的中国专利文献公开了一种治疗冠状动脉粥样硬化性心脏病的中药,由下述重量份的原料药制成:当归6-10 份,三七3-5 份,玄参6-8 份,金银花12-15 份,白薇5-9 份,灵芝14-18 份,葶苈子10-13 份、桑白皮8-10 份、降香6-8 份、延胡索10-12 份、党参15-20 份,甘草5-20 份,麦冬15-20 份,磁石20-25 份。申请公布号 CN 103550624 A(申请号 201310524895.4)的中国专利文献公开了一种治疗动脉粥样硬化与冠状动脉粥样硬化的养生粥,其主要原料及重量份分别是,当归30 份、川穹15 份、白芍18 份、麦芽30 份、红花12 份、昆布12 份、薄荷10 份、牛舌草30 份、芦根30 份。
总之,中医药在治疗本病方面取得了较好的疗效,但还存在一些问题:临床上对防治冠状动脉粥样硬化还需同步研究,对治疗冠状动脉粥样硬化出现的不适症状疗效也有待于进一步提高。
发明内容
针对现有技术的不足,本发明的目的是提供一种制备简单、服用方便、便于携带、易久服的治疗冠状动脉粥样硬化的养生粥,该养生粥疗效确切且无毒副作用。
本发明的技术方案是:
治疗冠状动脉粥样硬化的养生粥,主要由下列原料药制备而成,均为重量份:葶苈子2-6,苍耳子1-5,草问荆2-3,麦饭石2-6,延胡索3-8,姜黄3-6,枳壳1-5,淡菜1-5,淫羊藿2-5,银杏叶4-7,茯苓3-7,当归4-10,黄芪3-9,薏米20-40。
前面所述的治疗冠状动脉粥样硬化的养生粥,优选的是,主要由下列原料药制备而成,均为重量份:葶苈子3-5,苍耳子2-4,草问荆2.3-2.8,麦饭石3-5,延胡索5-7,姜黄4-5,枳壳2-4,淡菜2-4,淫羊藿3-4,银杏叶5-6,茯苓4-6,当归6-8,黄芪5-7,薏米25-35。
前面所述的治疗冠状动脉粥样硬化的养生粥,更佳优选的是,主要由下列原料药制备而成,均为重量份:葶苈子4,苍耳子3,草问荆2.5,麦饭石4,延胡索6,姜黄4.5,枳壳3,淡菜3,淫羊藿3.5,银杏叶5.5,茯苓5,当归7,黄芪6,薏米30。
所述治疗冠状动脉粥样硬化的养生粥的制备方法是:
(1)将薏米洗净,置于电饭锅内,加薏米重量1-3倍的水,浸泡50-70分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过80-120目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡1-3小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎0.5-1.5小时,过滤取汁,滤液静置4-6小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨30-50分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
上述养生粥的制备方法,步骤(1)加薏米重量1.5-2.5倍的水(优选的,加薏米重量2倍的水)。
上述养生粥的制备方法,步骤(2)细末过90-110目筛(优选的,细末过100目筛)。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤(3)加水浸泡1.5-2.5小时(优选的,加水浸泡2小时)。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤(3)滤液静置4.5-5.5小时后取上清液(优选的,滤液静置5小时后取上清液)。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,优选的是,步骤(4)在小火慢煨35-45分钟(优选的,在小火慢煨40分钟)。
本发明还提供了所述养生粥在制备治疗冠状动脉粥样硬化、心肌梗塞、心肌坏死、心绞痛的药物时的应用。
服用方法:为使本发明达到最佳效果,服用时,每次100-200ml,每天3次,随三餐服用,10天一个疗程。
本发明所用主要中药原料的药理如下:
葶苈子:葶苈子,别名:丁历、大适、大室,性味:辛;苦;寒。归经:肺经;心经;肝经;胃经;膀胱经。功能:泻肺降气;祛痰平喘;利水消肿;泄逐邪。主治:痰涎壅肺之喘咳痰多;肺痈;水肿;胸腹积水;小便不利;慢性肺源性心脏病;心力衰竭之喘肿;瘰疬结核。
苍耳子:苍耳子,又名:苍耳;别名:葈耳、粘头婆,虱马头、苍耳子、老苍子、野茄子、敝子、道人头、刺八裸、苍浪子、绵苍浪子、羌子裸子、青棘子、抢子、痴头婆,胡苍子、野茄、猪耳、菜耳,苍苍子,广东话又叫磁头芒(痴头芒)。苍耳子除了富含油脂类化合物之外,还有甾醇、倍半萜内酯和水溶性苷类。对血糖含量、心血管系统、呼吸系统、免疫系统等具有相应的药理作用。味辛、苦,性温,有毒。归肺经。具有散风除湿、通窍止痛的功能。生苍耳子以消风止痒力强。常用于皮肤痒疹及其他皮肤病。
草问荆:基原:为木贼科问荆属植物草问荆的全草。成分:全草内含黄酮类:槲皮素,山柰酚-3-双葡萄糖苷,山柰酚-3-芸香糖苷,山奈酚-3,7-双葡萄糖苷,槲皮素-3-芸香糖-7-葡萄糖苷,长链脂肪酸,等。药性:苦,平。功用主治:《长白山植物药志》:“用于动脉硬化的治疗,并可做利尿、驱肠寄生虫剂。”
麦饭石:基原:为中酸性火成岩类岩石石英二长斑岩。成分:中华麦饭石主要成分有二氧化硅,氧化铝,氧化铁,氧化亚铁,氧化镁,氧化钙,氧化钠,氧化钾,二氧化钛,五氧化二磷,氧化锰,二氧化碳,以及氟、硫、锶、钡、铜、锌等微量元素。药性:《纲目》:“甘,温,无毒。”功用主治:解毒生肌,祛湿健脾。主治痈疽发背,痤疮,湿疹,脚气,痱子,手指皲裂,黄褐斑,牙痛,口腔溃疡,风湿痹痛,腰背痛,慢性肝炎,胃炎,痢疾,糖尿病,神经衰弱,外伤红肿,高血压病,老年性血管硬化,肿瘤,尿路结石。一般作保健用品。宜忌:外敷时需研极细末,否则易引起疼痛。
延胡索:延胡索又名:延胡、玄胡索、元胡索、元胡等。性味:辛;苦;温;无毒。
2、归经:肝;胃;心;肺;脾经。3、主治:活血;散瘀;理气;止痛。主心腹腰膝诸痛;月经不调;症瘕;崩中;产后血晕;恶露不尽;跌打损伤。
姜黄:姜黄又名:郁金、宝鼎香、毫命、黄姜等。姜黄能行气破瘀,通经止痛。主治胸腹胀痛,肩臂痹痛,心痛难忍,产后血痛,疮癣初发,月经不调,闭经,跌打损伤。又可提取黄色食用染料;所含姜黄素可作分析化学试剂。
枳壳:本品为芸香科植物酸橙及其栽培变种的干燥未成熟果实。破气,行痰,消积。治胸膈痰滞,胸痞,胁胀,食积,噫气,呕逆,下痢后重,脱肛,子宫脱垂。
淡菜:咸,温。补肝肾,益精血,消瘿瘤。治虚劳羸瘦,眩晕,盗汗,阳痿,腰痛,吐血,崩漏,带下,瘿瘤,疝瘕。能补五脏,益阳事,理腰脚气,消宿食,除腹中冷气,痃癖。
淫羊藿:主要含黄酮类化合物、木脂素、生物碱、挥发油等,补肾壮阳,祛风除湿。治阳痿不举,偏风不遂,小便淋沥,筋骨挛急,咳嗽,病后青盲,虚火牙痛,半身不遂,腰膝无力,风湿痹痛,四肢不仁。
银杏叶:银杏叶它是一种落叶树的树叶,叶子形状像扇子。是一种具有很高药用价值的植物。可是生食有毒。味微苦,性平。具有益心、活血止痛、敛肺平喘、化湿止泻的功效。对心血管系统的作用:从银杏叶中提取的黄酮醇对豚鼠离体心脏灌流能引起冠状血管扩张;注射给药对豚鼠后肢血管亦有扩张作用.叶的粗提物(每毫升含总黄酮甙4.263mg)可对抗肾上腺素所致离体兔耳的血管收缩作用,总甙的作用较弱;对麻醉兔肌肉注射临床用量的20~40倍,对血压、呼吸均无影响.叶的提取制剂口服或静脉注射,可使巴金森病患者的脑血流量增加,改善脑的营养.
茯苓:茯苓(学名:Poria cocos(Schw.) Wolf.)别称:玉灵,茯菟,茯灵,茯蕶,伏苓、伏菟,松腴,绛晨伏胎,云苓,茯兔,松薯、松木薯,松苓。药用部位是多孔菌科真菌茯苓的菌核。具有利水渗湿,健脾,安神的功效。还可以制作成粉状用来女士爱好的美白面膜。
当归:当归,拉丁文名:Angelica sinensis,别名干归、秦哪、西当归、岷当归、金当归、当归身、涵归尾、当归曲、土当归,它是多年生草本植物,其根可入药,是最常用的中药之一。补血和血,调经止痛,润燥滑肠。用于血虚,面色萎黄,眩晕心悸;血虚,或兼有瘀滞的月经不调、经闭、痛经;虚寒性腹痛、冠心病心绞痛、风湿痹痛、跌打损伤等痛证;肠燥便秘;久咳气喘。
黄芪:黄芪,又名绵芪。其有增强机体免疫功能、保肝、利尿、抗衰老、抗应激、降压和较广泛的抗菌作用。但表实邪盛,气滞湿阻,食积停滞,痈疽初起或溃后热毒尚盛等实证,以及阴虚阳亢者,均须禁服。
本发明提供养生粥组方科学,各种剂型的制备方法简单,所得产品服用方便、便于携带。除此之外,本发明的优良效果还表现在:
1、所选材料皆为传统中药材料,无任何毒副作用;
2、本组方完全符合中医药原则和冠状动脉粥样硬化患者身心特点,在总原则的前提下,可根据不同人群有不同组方,功能不同。
3、药源易得,药材成本低廉,能够减轻患者负担。
具体实施方式
下面结合实施例和实验例详细说明本发明的技术方案,但保护范围不限于此。
实施例1 治疗冠状动脉粥样硬化的养生粥,由下列原料药制备而成,均为重量份(每份取10g):葶苈子2,苍耳子1,草问荆2,麦饭石2,延胡索3,姜黄3,枳壳1,淡菜1,淫羊藿2,银杏叶4,茯苓3,当归4,黄芪3,薏米20。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤是:
(1)将薏米洗净,置于电饭锅内,加薏米重量1倍的水,浸泡50分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过80目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡1小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎0.5小时,过滤取汁,滤液静置4小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨30分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
典型病例一:刘XX,男性,48岁,山东济南历城人士,某单位的领导,长期在外应酬,有胸闷气短的症状2年有余了,每日晚上睡觉都感觉胸闷的很厉害,都无法正常的入眠,怕冷、心悸、四肢欠温暖,疲乏无力,腿肿腰酸,胸痛彻背等症。去医院检查,心脏彩超显示有回流,运动平板车显示为阳性,动脉造影显示为动脉硬化,医生给予服用本发明养生粥,进行调养。
服用本实施例1所得养生粥,服用20天,胸闷,气短等症状明显减轻,疲乏无力亦减轻,纳量增,精神可,见有效果,又继续服用2个月,动脉造影显示为正常,继服4个月,不适症状消失,患者自感痊愈。
实施例2治疗冠状动脉粥样硬化的养生粥,由下列原料药制备而成,均为重量份(每份取15g):葶苈子6,苍耳子5,草问荆3,麦饭石6,延胡索8,姜黄6,枳壳5,淡菜5,淫羊藿5,银杏叶7,茯苓7,当归10,黄芪9,薏米40。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤是:
(1)将薏米洗净,置于电饭锅内,加薏米重量3倍的水,浸泡70分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过120目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡3小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎1.5小时,过滤取汁,滤液静置6小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨50分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
实施例3治疗冠状动脉粥样硬化的养生粥,由下列原料药制备而成,均为重量份(每份取25g):葶苈子3,苍耳子2,草问荆2.3,麦饭石3,延胡索5,姜黄4,枳壳2,淡菜2,淫羊藿3,银杏叶5,茯苓4,当归6,黄芪5,薏米25。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤是:
(1)将薏米洗净,置于电饭锅内,加薏米重量1.5倍的水,浸泡55分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过90目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡1.5小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎0.8小时,过滤取汁,滤液静置4.5小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨35分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
典型病例二:邹XX,年龄:46岁;性别:女性;农民,长期在工地打工,来诊时说,主诉:间歇性胸痛胸闷3个月;现病史:患者6小时前出现无明显诱因胸痛,为胸骨后闷痛,呈持续性,伴后背部放射,无腹胀,无腹痛,无恶心呕吐,无畏寒发热,无咳嗽咳痰。讨论:心脏彩超显示有回流,运动平板车显示为阳性,动脉造影显示为动脉硬化。
服用本实施例3所得养生粥,服用10天,饭量有所增加,不适症状有所改善,胸痛胸闷明显减轻,心中烦乱亦减轻,纳量增,精神可,服用20个月,症状消除,夜眠安,心烦除,力气增,纳食可,继服1个月,患者服用时未出现任何不适,患者自感痊愈。
实施例4 治疗冠状动脉粥样硬化的养生粥,由下列原料药制备而成,均为重量份(每份取5g):葶苈子5,苍耳子4,草问荆2.8,麦饭石5,延胡索7,姜黄5,枳壳4,淡菜4,淫羊藿4,银杏叶6,茯苓6,当归8,黄芪7,薏米35。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤是:
(1)将薏米洗净,置于电饭锅内,加薏米重量2.5倍的水,浸泡65分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过110目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡2.5小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎1.3小时,过滤取汁,滤液静置5.5小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨45分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
典型病例三:吴XX,50岁,男,工厂工人,于某日出现较以往更剧烈而频繁的心绞痛,心绞痛持续时间较以往长,诱因不明显,而且还伴有短时间的胸闷,气短症状,家里人给其服用救心丸来解决此症状,但疗效不好,去大医院做全面的检查上述症状是由冠状动脉粥样硬化引起的。
服用本实施例4所得养生粥,服用10天,胸闷、心绞痛明显减轻,恶心、呕吐症状消失,纳量增,精神可,服用20天,心电图示冠状动脉供血明显改善,继服3个月,患者痊愈。
实施例5 治疗冠状动脉粥样硬化的养生粥,由下列原料药制备而成,均为重量份(每份取20g):葶苈子4,苍耳子3,草问荆2.5,麦饭石4,延胡索6,姜黄4.5,枳壳3,淡菜3,淫羊藿3.5,银杏叶5.5,茯苓5,当归7,黄芪6,薏米30。
上述治疗冠状动脉粥样硬化的养生粥的制备方法,步骤是:
(1)将薏米洗净,置于电饭锅内,加薏米重量2倍的水,浸泡60分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过100目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡2小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎1小时,过滤取汁,滤液静置5小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨40分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
试验例1 实施例5所得治疗治疗冠状动脉粥样硬化养生粥的临床应用:2011年1月-2014年1月,在10所医院筛选400例患者,其中女性200例,男性200例,年龄最大的70岁,最小年龄40岁,平均年龄55岁。试验之前1周,对该人群进行连续观察,记录症状及变化,随机分为两组,实验组及对照组,实验组服用实施例5所得产品,对照组服用其它药品(美托洛尔、利多卡因、去甲肾上腺素等常规药品)。疗效情况判定标准:治愈:服用本品一个疗程,心电图示冠状动脉供血明显改善,不适症状消失,精力及体力明显增强;有效:服用本品一个疗程,心电图示慢性冠状动脉供血改善,不适症状减轻或部分消失,精力及体力增强;无效:服用本品一个疗程,不适症状无变化。结果如表1所示。
表1:服用实施例5产品40-70岁冠状动脉粥样硬化患者治疗结果
表1
本发明选择葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄、枳壳等进行配伍,使得这些药物组合后产生协同作用,诸药合用,活血而能养阴,祛瘀而不伤正,开窍而兼益气,故可获得良好的治疗效果。有效率高达99%,而对照组仅为65%。本发明所述养生粥具有活血通经,散淤止痛功效,对治疗动脉粥样硬化与冠心病有特殊的疗效。
Claims (10)
1.治疗冠状动脉粥样硬化的养生粥,其特征在于:主要由下列原料药制备而成,均为重量份:葶苈子2-6,苍耳子1-5,草问荆2-3,麦饭石2-6,延胡索3-8,姜黄3-6,枳壳1-5,淡菜1-5,淫羊藿2-5,银杏叶4-7,茯苓3-7,当归4-10,黄芪3-9,薏米20-40。
2.根据权利要求1所述的治疗冠状动脉粥样硬化的养生粥,其特征在于:主要由下列原料药制备而成,均为重量份:葶苈子3-5,苍耳子2-4,草问荆2.3-2.8,麦饭石3-5,延胡索5-7,姜黄4-5,枳壳2-4,淡菜2-4,淫羊藿3-4,银杏叶5-6,茯苓4-6,当归6-8,黄芪5-7,薏米25-35。
3.根据权利要求1所述的治疗冠状动脉粥样硬化的养生粥,其特征在于:主要由下列原料药制备而成,均为重量份:葶苈子4,苍耳子3,草问荆2.5,麦饭石4,延胡索6,姜黄4.5,枳壳3,淡菜3,淫羊藿3.5,银杏叶5.5,茯苓5,当归7,黄芪6,薏米30。
4. 根据权利要求1-3任一项所述的治疗冠状动脉粥样硬化的养生粥的制备方法是:其特征在于:步骤如下:
(1)将薏米洗净,置于电饭锅内,加薏米重量1-3倍的水,浸泡50-70分钟;
(2)将麦饭石打成硬币大小的块,置于容器内,放在无烟的炉火上锻制酥脆,研磨成细末,过80-120目筛,待用;
(3)将葶苈子、苍耳子、草问荆、麦饭石、延胡索、姜黄和枳壳置于砂锅内,加水浸泡1-3小时后,待水沸后,加人淡菜、淫羊藿、银杏叶、茯苓、当归和黄芪,再煎0.5-1.5小时,过滤取汁,滤液静置4-6小时,取上清液;
(4)将步骤(2)所得药物加入步骤(3)所得上清液中,小火煎煮至水沸时倒入步骤(1)所得浸泡好的薏米,大火迅速加热至沸腾后,在小火慢煨30-50分钟,加入蜂蜜,一边煎煮一边搅拌,待蜂蜜完全融化后装瓶密封即得。
5.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(1)加薏米重量1.5-2.5倍的水(优选的,加薏米重量2倍的水)。
6.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(2)细末过90-110目筛(优选的,细末过100目筛)。
7.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(3)加水浸泡1.5-2.5小时(优选的,加水浸泡2小时)。
8.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(3)滤液静置4.5-5.5小时后取上清液(优选的,滤液静置5小时后取上清液)。
9.根据权利要求4所述的养生粥的制备方法,其特征在于:步骤(4)在小火慢煨35-45分钟(优选的,在小火慢煨40分钟)。
10.根据权利要求1-3任一所述的治疗冠状动脉粥样硬化的养生粥还提供了在制备治疗冠心病、心肌梗塞、心肌坏死、心绞痛的养生粥时的应用。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410762969.2A CN104522493A (zh) | 2014-12-14 | 2014-12-14 | 治疗冠状动脉粥样硬化的养生粥及制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410762969.2A CN104522493A (zh) | 2014-12-14 | 2014-12-14 | 治疗冠状动脉粥样硬化的养生粥及制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104522493A true CN104522493A (zh) | 2015-04-22 |
Family
ID=52838270
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410762969.2A Pending CN104522493A (zh) | 2014-12-14 | 2014-12-14 | 治疗冠状动脉粥样硬化的养生粥及制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104522493A (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922504A (zh) * | 2015-05-29 | 2015-09-23 | 张慧玲 | 治疗动脉粥样硬化的醋饮及制备方法 |
CN105106924A (zh) * | 2015-10-12 | 2015-12-02 | 张明霞 | 计划生育室中治疗宫寒引起的不孕的养生粥品及制法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1244352A (zh) * | 1999-07-30 | 2000-02-16 | 河北省中医院 | 一种中老年保健方便药粥粉及制作方法 |
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
CN101697803A (zh) * | 2009-08-22 | 2010-04-28 | 王凯莹 | 一种药膳五谷薏仁粥及其制备方法 |
CN102973785A (zh) * | 2012-11-07 | 2013-03-20 | 溧阳市天目湖保健品有限公司 | 一种治疗糖尿病心肌病的中药 |
KR20130053661A (ko) * | 2011-11-15 | 2013-05-24 | 산청기능성콩 영농조합법인 | 다이어트 고구마죽의 제조방법 |
CN103656568A (zh) * | 2013-11-25 | 2014-03-26 | 张秀丽 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
CN103860773A (zh) * | 2014-04-11 | 2014-06-18 | 胡海波 | 用于治疗心肌缺血的中药组合物及其制备方法 |
-
2014
- 2014-12-14 CN CN201410762969.2A patent/CN104522493A/zh active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1244352A (zh) * | 1999-07-30 | 2000-02-16 | 河北省中医院 | 一种中老年保健方便药粥粉及制作方法 |
CN1334121A (zh) * | 2001-08-31 | 2002-02-06 | 石家庄以岭药业有限公司 | 一种通心络药物组合物及应用 |
CN101697803A (zh) * | 2009-08-22 | 2010-04-28 | 王凯莹 | 一种药膳五谷薏仁粥及其制备方法 |
KR20130053661A (ko) * | 2011-11-15 | 2013-05-24 | 산청기능성콩 영농조합법인 | 다이어트 고구마죽의 제조방법 |
CN102973785A (zh) * | 2012-11-07 | 2013-03-20 | 溧阳市天目湖保健品有限公司 | 一种治疗糖尿病心肌病的中药 |
CN103656568A (zh) * | 2013-11-25 | 2014-03-26 | 张秀丽 | 一种治疗心脑血管疾病的中药组合物及其制备方法 |
CN103860773A (zh) * | 2014-04-11 | 2014-06-18 | 胡海波 | 用于治疗心肌缺血的中药组合物及其制备方法 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104922504A (zh) * | 2015-05-29 | 2015-09-23 | 张慧玲 | 治疗动脉粥样硬化的醋饮及制备方法 |
CN105106924A (zh) * | 2015-10-12 | 2015-12-02 | 张明霞 | 计划生育室中治疗宫寒引起的不孕的养生粥品及制法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103211930A (zh) | 一种降血脂、降血压的中药制剂 | |
CN104687198B (zh) | 一种具有补气安神功效的保健饮品及制备方法 | |
CN104489518A (zh) | 治疗神经衰弱的养生粥及制备方法 | |
CN105596777A (zh) | 一种疏通血管降血压的中药 | |
CN104873826A (zh) | 一种可清肺祛湿的茶饮及其制备方法 | |
CN103919910A (zh) | 一种治疗冠心病的药物 | |
CN104522493A (zh) | 治疗冠状动脉粥样硬化的养生粥及制备方法 | |
CN104605372A (zh) | 一种基于恶性肿瘤放疗患者的营养药膳及制备方法 | |
CN102908425B (zh) | 一种治疗心脏病及血脂稠的药物及其制备方法 | |
CN104623417A (zh) | 提高肿瘤患者术后免疫功能的营养药膳及制法 | |
CN104043058A (zh) | 一种治疗肾虚型腰椎间盘突出的中药制剂及其制备方法 | |
CN103845670B (zh) | 治疗冠状动脉粥样硬化的冲剂及制备方法 | |
CN103006909A (zh) | 一种治疗高血压病组合药物 | |
CN102846113A (zh) | 一种桑叶保健枕芯及其制备方法 | |
CN104258224A (zh) | 一种治疗肺肾阴虚型慢性支气管炎的五味子口服液及其制备方法 | |
CN105394279A (zh) | 一种添加中药的降脂减肥茶及其制备方法 | |
CN109771567A (zh) | 一种中草药扶正化瘀排毒化肿瘤的配方 | |
CN106822852A (zh) | 治疗冠心病的药物组合物、其制备工艺及用途 | |
CN105596848A (zh) | 一种主治外痔的制剂及制法 | |
CN103933368B (zh) | 用于治疗产后便秘的药物组合物及其制备方法 | |
CN105596849A (zh) | 医治外痔的中药熏洗液及制备方法 | |
CN104435659A (zh) | 治疗冠状动脉粥样硬化性心脏病心绞痛的中药片剂及其制备方法 | |
CN105056073A (zh) | 医治心律失常的中药制剂及制备方法 | |
CN104491263A (zh) | 食道癌活血化瘀药剂及制备方法 | |
CN105709071A (zh) | 用于治疗产后便秘的药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150422 |
|
RJ01 | Rejection of invention patent application after publication |